Cannabismarketcap

CV Sciences Stock Forecast & Price Prediction 2026-2027

Algorithmic price targets and analysis for CVSI based on fundamentals, valuation multiples, and historical data.

$0.0083-10.80%
Neutral

Price Target Summary

Bear Case
$0.0067
-18.7% from current
Base Case
$0.12
+1346.3% from current
Bull Case
$0.22
+2503.3% from current

Technical Outlook

52-Week Range Analysis

$0.0071$0.10
Current: $0.0083
Support Level
$0.0164
Resistance Level
$0.0907
From 52W High
-91.7%
From 52W Low
+16.9%

Fundamental Analysis

Revenue Growth Projection

Year 1 Projected
$10.8M
Year 2 Projected
$9.6M
Year 3 Projected
$8.7M

Based on -14.9% YoY growth, tapered 20% per year in outer projections.

Valuation vs Peers

Current P/S
0.15x
Sector Median P/S
2.5x
Assessment
Undervalued vs sector

Cash Position

Cash on Hand
$266.0K
Total Debt
$18.0K
Cash Runway
6 mo

Key Metrics

Current Price$0.0083
Market Cap$1.9M
P/S Ratio0.15x
Revenue (TTM)$12.7M
Revenue Growth (YoY)-14.9%
Gross Margin49.1%
Cash on Hand$266.0K
Total Debt$18.0K
52W High$0.10
52W Low$0.0071

Signal Breakdown

Overall Signal: Neutral
  • Negative or flat revenue growth
  • Healthy gross margins above 40%
  • Cash exceeds total debt
  • Trading more than 50% below 52-week high
  • P/S ratio below sector median suggests upside

Risk Factors

  • Revenue is declining year-over-year (-14.9%), which may pressure valuation multiples.
  • Limited cash runway: approximately 6 months of cash remaining at current burn rate.
  • Penny stock status (below $1.00) carries heightened volatility and delisting risk.

Analyst Summary

CV Sciences (CVSI) is a CBD and hemp company with contracting revenue and a market capitalization of $1.9M. Based on trailing revenue of $12.7M and a P/S ratio of 0.15x, the stock appears undervalued relative to the sector median of 2.5x. Our algorithmic base-case price target of $0.12 implies upside of 1346.3% from current levels. The overall signal is neutral, with a mixed fundamental picture. Investors should weigh the 3 identified risk factors before making any investment decision.

Frequently Asked Questions

What is the price target for CVSI?+
Our algorithmic base-case price target for CV Sciences (CVSI) is $0.12, with a bear case of $0.0067 and a bull case of $0.22. These targets are derived from sector-average and premium P/S multiples applied to projected revenue.
Is CVSI a buy right now?+
Based on our algorithmic analysis, CVSI currently carries a neutral signal. Negative or flat revenue growth. Healthy gross margins above 40%. This is not a buy or sell recommendation — always do your own due diligence.
What is the revenue forecast for CV Sciences?+
Based on the current year-over-year growth rate of -14.9%, we project CVSI revenue at $10.8M in Year 1, $9.6M in Year 2, and $8.7M in Year 3. Growth rates are tapered in outer years.
What are the risks of investing in CVSI?+
Revenue is declining year-over-year (-14.9%), which may pressure valuation multiples. Limited cash runway: approximately 6 months of cash remaining at current burn rate. Penny stock status (below $1.00) carries heightened volatility and delisting risk.
How does CVSI valuation compare to the cannabis sector?+
CVSI has a trailing P/S ratio of 0.15x compared to the cannabis sector median of 2.5x. The stock undervalued vs sector.

Important Disclaimer

This is not financial advice. Forecasts are algorithmic projections based on historical data and should not be used as the sole basis for investment decisions. Past performance does not guarantee future results. Cannabis stocks carry significant risk including regulatory, market, and operational risks. Always consult with a qualified financial advisor before making investment decisions. Cannabismarketcap does not recommend buying, selling, or holding any security.

← Back to CVSI OverviewAll Cannabis Stocks